Liu, "A realistic appraisal of boron neutron capture therapy
as a cancer treatment modality," Cancer Communications, vol.
Boron neutron capture therapy
(BNCT) is now being used to treat deep-seated brain tumors, particularly glioblastoma multiforme, and is being tested for treating cancer at other locations as well.
Boron neutron capture therapy for glioblastoma multiforme: interim results from the phase I/II dose-escalation studies.
Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I and II.
Medical technology company RaySearch Laboratories AB (STO:RAYB) announced on Monday that it has entered into an agreement with Neutron Therapeutics Inc, a US based medical equipment company that is developing a comprehensive solution for boron neutron capture therapy
(BNCT), regarding treatment planning for BNCT, which is a unique type of radiation therapy that enables targeting of cancer at the cellular level.
The surgery - called boron neutron capture therapy
- involved attaching boron atoms to the amino acid phenylalanine and injecting them into the patient.
The major event of the year was the inauguration of the boron neutron capture therapy
(BNCT) cancer treatment facility.
The treatment, called Boron Neutron Capture Therapy
, has already been tested successfully on patients in the United States.
In case our filler last month on boron neutron capture therapy
(BNCT) piqued your curiosity, here is some more on this high tech approach to dealing with some of the deadlier cancers.
In the BNCT method (boron neutron capture therapy
), patients are injected with a boron compound - a chemical used to harden steel.